Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “MRD”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07243015
What this trial is testing

Detection of Minimal Residual Disease Using Exosomal miRNA Distant Metastasis Markers

Who this might be right for
Gastric Cancer
City of Hope Medical Center 500
Testing effectiveness (Phase 2)Ended earlyNCT04216563
What this trial is testing

ABL001 for the Treatment of Chronic Myeloid Leukemia in Patients Who Are on Therapy With Tyrosine Kinase Inhibitor

Who this might be right for
Philadelphia Chromosome Negative, BCR-ABL1 Positive Chronic Myelogenous Leukemia
M.D. Anderson Cancer Center 7
Not applicableLooking for participantsNCT06893133
What this trial is testing

CtDNA-MRD Monitoring After Resection in Gastric Cancer

Who this might be right for
Gastric Cancer
Peking University 110
Large-scale testing (Phase 3)Looking for participantsNCT04168502
What this trial is testing

Gemtuzumab Chemotherapy MRD Levels; Adult Untreated, de Novo, Fav Interm Risk AML

Who this might be right for
Acute Myeloid Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto 414
Not applicableStudy completedNCT03751072
What this trial is testing

Efficacy and Toxicity of Blinatumomab in the French ATU for Adult BCP-ALL R/R, or With MRD+ (FRENCH-CYTO)

Who this might be right for
Acute Lymphoblastic Leukemia, in RelapseAcute Lymphoblastic Leukemia With Failed Remission
Group for Research in Adult Acute Lymphoblastic Leukemia 92
Not applicableLooking for participantsNCT06401421
What this trial is testing

EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)

Who this might be right for
Breast Cancer
Exact Sciences Corporation 1,800
Testing effectiveness (Phase 2)UnknownNCT03697707
What this trial is testing

Efficacy and Safety of Immunotherapy With Allogeneic Dendritic Cells, DCP-001, in Patients With Acute Myeloid Leukaemia

Who this might be right for
Acute Myeloid Leukemia in Remission
Mendus 20
Large-scale testing (Phase 3)Study completedNCT02870777
What this trial is testing

MRD-directed Therapy for Low-risk and Intermediate-risk AML.

Who this might be right for
Acute Myeloid LeukemiaMinimal Residual Disease
Nanfang Hospital, Southern Medical University 743
Not applicableLooking for participantsNCT07393048
What this trial is testing

Application and Exploration of Personalized ctDNA-MRD Detection Technology in Predicting the Efficacy of Neoadjuvant Therapy for Rectal Cancer

Who this might be right for
Locally Advanced Rectal Cancer (LARC)
Beijing Friendship Hospital 60
Not applicableLooking for participantsNCT06875609
What this trial is testing

CtDNA in Cutaneous Squamous Cell Carcinoma

Who this might be right for
Cutaneous Squamous Cell Carcinoma
Massachusetts Eye and Ear Infirmary 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT03863184
What this trial is testing

Acalabrutinib-Lenalidomide-Rituximab in Patients With Untreated MCL

Who this might be right for
Mantle Cell Lymphoma
Weill Medical College of Cornell University 37
Testing effectiveness (Phase 2)Study completedNCT03367299
What this trial is testing

Sequential Chemotherapy and Blinatumomab to Improve MRD Response and Survival in Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoid LeukemiaPhiladelphia Chromosome-Negative B-Cell Precursor
Gruppo Italiano Malattie EMatologiche dell'Adulto 149
Testing effectiveness (Phase 2)Ended earlyNCT03769532
What this trial is testing

MRD-guided Treatment in NPM1mut AML Patients

Who this might be right for
Acute Myeloid Leukemia
Technische Universität Dresden 26
Not applicableLooking for participantsNCT06230185
What this trial is testing

CtDNA Based MRD Testing for NAC Monitoring in TNBC

Who this might be right for
TNBC - Triple-Negative Breast CancerMinimal Residual Disease
Personalis Inc. 422
Not applicableStudy completedNCT03433365
What this trial is testing

Monitoring of Deep of Response During Lenalidomide Maintenance in MM Patients Achieving at Least Very Good Partial Response (MRD)

Who this might be right for
Multiple Myeloma
Fondazione EMN Italy Onlus 70
Not applicableLooking for participantsNCT07211178
What this trial is testing

Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies

Who this might be right for
Breast CancerTNBC - Triple-Negative Breast CancerHR Positive/HER-2 Negative Breast Cancer+2 more
Tempus AI 900
Not applicableActive Not RecruitingNCT06867146
What this trial is testing

MRD in PAAD Adjuvant Therapy

Who this might be right for
The Role of Molecular Residual Disease in the Treatment Strategy and Prognosis Prediction of Pancreatic Cancer Patients Undergoing Adjuvant TherapyMolecular Residual DiseasePancreatic Cancer+1 more
Peking Union Medical College Hospital 60
Large-scale testing (Phase 3)Looking for participantsNCT07441291
What this trial is testing

CD19 CAR-T vs DLI for Post-HSCT MRD in Ph- ALL: A RCT

Who this might be right for
B ALLAllogenetic Hematopoietic Stem Cell TransplantationMRD-positive
Peking University People's Hospital 70
Testing effectiveness (Phase 2)Active Not RecruitingNCT07134088
What this trial is testing

Subcutaneous Blinatumomab in Children With R/R and and MRD+ B-Cell Precursor Acute Lymphoblastic Leukemia

Who this might be right for
Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic LeukemiaMinimal Residual Disease + B-Cell Acute Lymphoblastic Leukemia
Amgen 104
Not applicableNot Yet RecruitingNCT07112612
What this trial is testing

Minimal Residual Disease Used in Predicting Therapeutic Efficacy in Metastatic Hormone-sensitive Prostate Cancer

Who this might be right for
MRDProstate CancermHSPC
Anhui Medical University 50
Next Page